Arsenic Levels in Drinking Water Tied to Elevated Bladder Cancer Risk
Low-to-moderate levels of arsenic in drinking water were linked to increased risk for bladder cancer.
Low-to-moderate levels of arsenic in drinking water were linked to increased risk for bladder cancer.
18F-fluorodeoxyglucose positron emission tomography at diagnosis provided a “very useful predictive tool” for soft tissue sarcoma and bone sarcoma.
Safety and feasibility of CD19 CAR TCM therapy post-myeloablative HSCT were established in non Hodgkin lymphoma.
Surveillance of CDNK2A mutation carriers is relatively successful, detecting most pancreatic ductal adenocarcinoma (PDAC) at a resectable stage.
Addition of metformin therapy following pancreatic ductal adenocarcinoma diagnosis does not appear to have an added patient benefit.
Proposed biosimilar LA-EP2006 and reference pegfilgrastim were comparable regarding efficacy and safety in the prevention of neutropenia.
Elotuzumab seemed to provide clinical benefit in patients with relapsed/refractory multiple myeloma.
Pemetrexed-containing regimens should be considered in patients with RET-rearranged lung cancer.
Two nomograms are reliable prognostic methods that can be used to predict overall survival and distant metastases.
Gemcitabine-oxaliplatin or 5-fluourouracil-oxaliplatin combinations are promising chemotherapy regimens in metastatic pulmonary carcinoid tumors.